Gmi Research's blog : Dual Prefilled Syringes Market Size, Report, Trends Analysis 2029
Dual Chamber Prefilled Syringes Market
Dual Chamber Prefilled Syringes Market is projected to grow at a CAGR of 7.3% from 2022-2029.
The factors driving the growth of Dual Chamber Prefilled Syringes Market includes rising prevalence of diabetes, influenzas, and cardiovascular disease around the world, increasing geriatric population, expansion of the pharmaceutical industry and growing demand for lyophilized drugs. According to the report published by the United Nations, the population aged 65 and above was calculated around 703 million in 2019 and is expected to reach 1.5 billion by the end of 2050, which will push the demand for dual chamber prefilled syringes in the approaching years. Moreover, availability of dual chamber prefilled syringes at the online pharmaceutical stores, rise in the launch of innovative products and growing adoption of advanced technologies by manufacturers, are some of the additional factors supplementing the market growth. In addition, the increasing investment by leading players on research and development, rising awareness amongst consumers about the benefits of dual chamber prefilled syringes, rapid urbanization, and growing population growth rates, are further contributing towards the market growth.
Request a free sample of this report
However, the growth of Dual Chamber Prefilled Syringes Market is hindered due to risk of cross-contamination.
The leading player operating in the market are AbbVie Inc., Schott Ag, Credence Med systems, Maeda Industry, Ypsomed AG, Otsuka America Pharmaceutical, Inc., Pfizer Inc., Arte Corporation, Gerresheimer AG, Vetter Pharma, and Nipro Corporation, among others.
Based on Product, the <1 ml segment is predicted to grow at a significant CAGR during the forecast period
As per the Dual Chamber Prefilled Syringes Market Forecast, rise in the launch of innovative syringe products and increasing prevalence of chronic diseases, are some of the factors pushing the growth of the segment.
Based on Material, the Glass segment is projected to capture the largest market share over the forecast period
Glass based dual chamber prefilled syringes are available in different sizes and have high precision, are propelling the growth of the segment.
Based on Region, the North American region is anticipated to hold the highest market share during the forecast period
Rising prevalence of chronic diseases such as diabetes and cardiovascular diseases, presence of the leading pharmaceutical companies such as Pfizer and Novartis, improved living standards, rising population growth rates and high per capita income, are some of the important factors augmenting the market growth in North America.
Key Development
- In 2019, Gerresheimer AG invested in manufacturing plastic systems of prefillable syringes, at its new plant in Skopje, North Macedonia. Company expects to enhance the production capacity through this plant and is likely to be operational from the second half of 2020.
Market Segmentation
Segmentation by Product
- <1 ml
- 1 ml-2.5 ml
- 5 ml-5.0 ml
- >5.0 ml
Segmentation by Material
- Glass
- Plastic
Segmentation by Indication
- Hemophilia
- Schizophrenia
- Diabetes
- Erectile Dysfunction
- Endometriosis
- Others
Segmentation by Region
- Asia Pacific
- China
- Japan
- India
- Rest of APAC
- North America
- United States of America
- Canada
- Europe
- United Kingdom
- Germany
- France
- Spain
- Rest of Europe
- RoW
- Brazil
- South Africa
- Saudi Arabia
- UAE
About GMI Research
GMI Research is a market research and consulting firm which provides market insights and intelligence across 12 major sectors helping our clients in making effective investment and business decisions.
Media Contact
Company Name: GMI RESEARCH
Contact Person: Sarah Nash
Email: enquiry@gmiresearch.com
Phone: Europe – +353 1 442 8820; US – +1 860 881 2270
Address: Dublin, Ireland
Website: https://www.gmiresearch.com/
- News